Authorities have identified hundreds of violations following a court-directed survey of nearly 5,100 properties ...
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease ...
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Novocure (NASDAQ:NVCR) shares dropped 10% after the company reported that its Phase 3 TRIDENT trial failed to achieve its ...
BeOne Medicines Ltd. (NASDAQ:ONC) is one of the high-growth large-cap stocks to invest in. On June 11, BeOne Medicines Ltd.
Intellia Therapeutics shares rose after the gene-editing therapeutics company reported positive Phase 3 results for its experimental treatment for hereditary angioedema, a rare genetic condition that ...
DTCP sealed seven properties in Gurugram for illegal commercial use as PG accommodations, violating residential zoning rules, ...
TD Cowen analysts said amlitelimab readouts are “mission critical” for Sanofi. (iStock / Getty Images Plus) A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key ...
Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...
Kardigan’s IPO haul has come in 14% above expectations, grossing $400 million after the cardiovascular disease biotech upsized the offering and hit the top end of its target range. Last week, Kardigan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results